Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
- PMID: 22649780
- PMCID: PMC3355902
- DOI: 10.3389/fonc.2012.00021
Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease
Abstract
The cullin 4-RING ubiquitin ligase (CRL4) family employs multiple DDB1-CUL4 associated factors substrate receptors to direct the degradation of proteins involved in a wide spectrum of cellular functions. Aberrant expression of the cullin 4A (CUL4A) gene is found in many tumor types, while mutations of the cullin 4B (CUL4B) gene are causally associated with human X-linked mental retardation. This focused review will summarize our current knowledge of the two CUL4 family members in the pathogenesis of human malignancy and neuronal disease, and discuss their potential as new targets for cancer prevention and therapeutic intervention.
Keywords: CRL; CUL4A; CUL4B; cancer; cullin; disease.
Figures

Similar articles
-
Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B.Gene. 2015 Nov 15;573(1):33-45. doi: 10.1016/j.gene.2015.08.064. Epub 2015 Sep 3. Gene. 2015. PMID: 26344709 Free PMC article. Review.
-
The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.Oncotarget. 2015 Dec 15;6(40):42590-602. doi: 10.18632/oncotarget.6052. Oncotarget. 2015. PMID: 26460955 Free PMC article. Review.
-
The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.J Mol Med (Berl). 2023 Feb;101(1-2):171-181. doi: 10.1007/s00109-022-02277-1. Epub 2023 Jan 23. J Mol Med (Berl). 2023. PMID: 36688959
-
Small molecule NSC1892 targets the CUL4A/4B-DDB1 interactions and causes impairment of CRL4DCAF4 E3 ligases to inhibit colorectal cancer cell growth.Int J Biol Sci. 2020 Feb 4;16(6):1059-1070. doi: 10.7150/ijbs.40235. eCollection 2020. Int J Biol Sci. 2020. PMID: 32140073 Free PMC article.
-
The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A.Cancer Res. 2008 Jul 1;68(13):5014-22. doi: 10.1158/0008-5472.CAN-07-6162. Cancer Res. 2008. PMID: 18593899
Cited by
-
CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription.Cell Mol Immunol. 2021 Feb;18(2):339-349. doi: 10.1038/s41423-019-0323-0. Epub 2019 Nov 15. Cell Mol Immunol. 2021. PMID: 31729464 Free PMC article.
-
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer.Clin Transl Med. 2025 Feb;15(2):e70078. doi: 10.1002/ctm2.70078. Clin Transl Med. 2025. PMID: 39856363 Free PMC article.
-
Clinical significance of CUL4A in human prostate cancer.Tumour Biol. 2015 Nov;36(11):8553-8. doi: 10.1007/s13277-015-3580-2. Epub 2015 Jun 3. Tumour Biol. 2015. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 26036759 Retracted.
-
CSN-CRL Complexes: New Regulators of Adipogenesis.Biomolecules. 2025 Mar 5;15(3):372. doi: 10.3390/biom15030372. Biomolecules. 2025. PMID: 40149914 Free PMC article. Review.
-
The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies.Chin J Cancer. 2013 Sep;32(9):478-82. doi: 10.5732/cjc.012.10279. Epub 2013 Jul 12. Chin J Cancer. 2013. PMID: 23845142 Free PMC article. Review.
References
-
- Angers S., Li T., Yi X., MacCoss M. J., Moon R. T., Zheng N. (2006). Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443, 590–593 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources